Trial intelligence / Profile preview

Botox for Cervical Dystonia and Myofascial Pain

NCT00178945Phase 2Completed

Sponsor
Vanderbilt University
Start
Mar 2004
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in cervical dystonia (CD), myofascial pain syndrome (MPS), sponsored by Vanderbilt University. Started Mar 2004; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

cervical dystonia (CD)myofascial pain syndrome (MPS)

Beyond the preview

Go deeper on NCT00178945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00178945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call